devadmin No Comments

Merion Exits its Investment in RPS

ReSearch Pharmaceutical Services to be Acquired by Warburg Pincus

RPS Press Release

Fort Washington, PA — ReSearch Pharmaceutical Services, Inc. (RPS) announced today it has entered into an agreement to sell the company to affiliates of Warburg Pincus, LLC, the global private equity firm, in an all cash transaction valued at $6.10 per share. The Board of Directors of RPS unanimously approved the acquisition agreement and recommended that RPS shareholders approve the transaction. It is presently anticipated that closing of the transaction will occur in February 2011. Read more